64 related articles for article (PubMed ID: 23185784)
1. Modulation of IL-10/IL-10R expression by mafosfamide, a derivative of 4-hydroxycyclophosphamide, in a rat B-cell lymphoma.
Rico MJ; Matar P; Scharovsky OG
Biocell; 2012 Aug; 36(2):91-5. PubMed ID: 23185784
[TBL] [Abstract][Full Text] [Related]
2. The transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretion.
Rico MJ; Matar P; Gervasoni SI; Bonfil RD; Calcaterra N; Scharovsky OG
Clin Exp Metastasis; 2005; 22(2):127-35. PubMed ID: 16086233
[TBL] [Abstract][Full Text] [Related]
3. Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model.
Matar P; Rozados VR; Gervasoni SI; Scharovsky GO
Cancer Immunol Immunother; 2002 Jan; 50(11):588-96. PubMed ID: 11807622
[TBL] [Abstract][Full Text] [Related]
4. Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model.
Zacarías Fluck MF; Rico MJ; Gervasoni SI; Ilarregui JM; Toscano MA; Rabinovich GA; Scharovsky OG
Cancer Immunol Immunother; 2007 Feb; 56(2):237-48. PubMed ID: 16733672
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide.
Davidoff AN; Mendelow BV
Exp Hematol; 1993 Jul; 21(7):922-7. PubMed ID: 8319782
[TBL] [Abstract][Full Text] [Related]
6. Oxazaphosphorine effects in L 5222 rat leukemia.
Pohl J; Reissmann T; Voegeli R
Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):589-94. PubMed ID: 3437788
[TBL] [Abstract][Full Text] [Related]
7. The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression.
Rabinovich GA; Rubinstein N; Matar P; Rozados V; Gervasoni S; Scharovsky GO
Cancer Immunol Immunother; 2002 Jan; 50(11):597-603. PubMed ID: 11807623
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the antimetastatic effect of a single low dose of cyclophosphamide on rat lymphoma.
Matar P; Rozados VR; Roggero EA; Bonfil RD; Scharovsky OG
Tumour Biol; 1998; 19(2):69-76. PubMed ID: 9486558
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
Botzler C; Kis K; Issels R; Multhoff G
Exp Hematol; 1997 Apr; 25(4):338-44. PubMed ID: 9131009
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
15. Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response.
Matar P; Rozados VR; Gervasoni SI; Scharovsky OG
Int Immunopharmacol; 2001 Feb; 1(2):307-19. PubMed ID: 11360931
[TBL] [Abstract][Full Text] [Related]
16. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.
Martinez-Forero I; Garcia-Munoz R; Martinez-Pasamar S; Inoges S; Lopez-Diaz de Cerio A; Palacios R; Sepulcre J; Moreno B; Gonzalez Z; Fernandez-Diez B; Melero I; Bendandi M; Villoslada P
Eur J Immunol; 2008 Feb; 38(2):576-86. PubMed ID: 18200504
[TBL] [Abstract][Full Text] [Related]
17. Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides.
Brignole C; Marimpietri D; Pastorino F; Di Paolo D; Pagnan G; Loi M; Piccardi F; Cilli M; Tradori-Cappai A; Arrigoni G; Pistoia V; Ponzoni M
J Control Release; 2009 Sep; 138(2):122-7. PubMed ID: 19427884
[TBL] [Abstract][Full Text] [Related]
18. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.
Michel G; Mirmohammadsadegh A; Olasz E; Jarzebska-Deussen B; Müschen A; Kemény L; Abts HF; Ruzicka T
J Immunol; 1997 Dec; 159(12):6291-7. PubMed ID: 9550434
[TBL] [Abstract][Full Text] [Related]
19. IL-10 receptor and coreceptor expression in quiescent and activated hepatic stellate cells.
Mathurin P; Xiong S; Kharbanda KK; Veal N; Miyahara T; Motomura K; Rippe RA; Bachem MG; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G981-90. PubMed ID: 12016123
[TBL] [Abstract][Full Text] [Related]
20. High-dose selection with mafosfamide results in sensitivity to DNA cross-linking agents: characterization of hypersensitive cell lines.
Fritz G; Hengstler JG; Kaina B
Cancer Res; 1997 Feb; 57(3):454-60. PubMed ID: 9012473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
